New stock news | Lontium Semiconductor Corporation (688486.SH) plans to list in Hong Kong. The China Securities Regulatory Commission requires additional explanation of the issuance plan.
China Securities Regulatory Commission issued the "Supplementary Materials Requirements for Overseas Issuance and Listing Record Filing (January 26, 2026 - January 30, 2026)".
The China Securities Regulatory Commission has issued the "Requirements for Supplementary Materials for Overseas Issuance and Listing Filing (January 26, 2026 - January 30, 2026)." The International Department of the China Securities Regulatory Commission has issued supplementary material requirements for 6 companies, including Lontium Semiconductor Corporation (688486.SH), requiring them to explain the issuance plan in accordance with the "Regulatory Rules Applicable Guidelines - Overseas Issuance Listing No. 2".
According to the disclosure of the Hong Kong Stock Exchange on December 22, Lontium Semiconductor Corporation (also known as Lontium Semiconductor Corporation) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with China Securities Co., Ltd. International as the exclusive sponsor.
The China Securities Regulatory Commission has requested Lontium Semiconductor Corporation to provide clarification on the following matters, and to have lawyers verify and provide clear legal opinions:
- The content related to the issuance plan in the filing materials and prospectus should be consistent. Please explain the issuance plan in accordance with the requirements of the "Regulatory Rules Applicable Guidelines - Overseas Issuance Listing No. 2".
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


